{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:48:41Z","timestamp":1793051321912,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474351"],"award-info":[{"award-number":["82474351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301028"],"award-info":[{"award-number":["82301028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371020"],"award-info":[{"award-number":["82371020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qin Chuang Yuan Traditional Chinese Medicine Industry Innovation Agglomeration Zone Project of Xianyang","award":["L2024-QCY-ZYYJJQ-X25"],"award-info":[{"award-number":["L2024-QCY-ZYYJJQ-X25"]}]},{"name":"Project of State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration","award":["2024KA01"],"award-info":[{"award-number":["2024KA01"]}]},{"name":"Project of State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration","award":["2024MS04"],"award-info":[{"award-number":["2024MS04"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["BX20230485"],"award-info":[{"award-number":["BX20230485"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1100600"],"award-info":[{"award-number":["2021YFA1100600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Provincial Innovation Capacity Enhancement Program","award":["2023-CX-PT-33"],"award-info":[{"award-number":["2023-CX-PT-33"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 2 diabetes (T2D) and its complications represent a complex disorder involving multiple pathophysiological processes. Although conventional therapeutic approaches partially regulate blood glucose, they fail to fundamentally reverse disease progression or effectively prevent complications. This review summarizes the current research advance and challenges of using different forms of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in treating T2D and complications. It begins with an introduction to the characteristics of MSC-EVs. Subsequently, the mechanisms and therapeutic prospects of natural MSC-EVs are analyzed, with a focus on their roles in inflammatory modulation, tissue regeneration, and improving insulin resistance. Engineering MSC-EVs, covering strategies including optimizing MSC culture conditions, modifying EV contents, and establishing MSC-EV delivery systems based on bioactive materials are then discussed, which boost EV yield and quality while enhancing therapeutic efficacy. Current challenges, including the limited yield and high heterogeneity of natural MSC-EVs, as well as issues related to long-term safety, immunocompatibility, and large-scale production of engineered MSC-EVs are finally overviewed, with emphasizing artificial intelligence in guiding future research directions. These summaries are crucial for clinical translation of MSC-EVs and will ultimately provide T2D patients with an effective and safe treatment option.<\/jats:p>","DOI":"10.1186\/s13287-026-04991-w","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T06:14:38Z","timestamp":1774764878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mesenchymal stem cell-derived extracellular vesicles in the treatment of type 2 diabetes and its complications: current progress and future directions"],"prefix":"10.1186","volume":"17","author":[{"given":"Sha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Dong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"4991_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00508-022-02122-y","volume":"135","author":"J Harreiter","year":"2023","unstructured":"Harreiter J, Roden M. [Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)]. Wien Klin Wochenschr. 2023;135:7\u201317.","journal-title":"Wien Klin Wochenschr"},{"key":"4991_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"4991_CR3","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"4991_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068\u201383.","journal-title":"Lancet"},{"key":"4991_CR5","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.1073\/pnas.0705408104","volume":"104","author":"KF Petersen","year":"2007","unstructured":"Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4991_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333\u201346.","journal-title":"Lancet"},{"key":"4991_CR7","first-page":"20240133","volume":"5","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhang K, Zheng C-X, Gao Y-F, Deng G-R, Zhang X, et al. D-Mannose Alleviates Type 2 Diabetes and Rescues Multi-Organ Deteriorations by Controlling Release of Pathological Extracellular Vesicles. Explor (Beijing). 2025;5:20240133.","journal-title":"Explor (Beijing)"},{"key":"4991_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pop.2021.11.004","volume":"49","author":"J Teck","year":"2022","unstructured":"Teck J. Diabetes-Associated Comorbidities. Prim Care. 2022;49:275\u201386.","journal-title":"Prim Care"},{"key":"4991_CR9","doi-asserted-by":"publisher","first-page":"8852759","DOI":"10.1155\/2021\/8852759","volume":"2021","author":"L Deng","year":"2021","unstructured":"Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, et al. The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing. Oxid Med Cell Longev. 2021;2021:8852759.","journal-title":"Oxid Med Cell Longev"},{"key":"4991_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12015-020-10014-9","volume":"17","author":"T An","year":"2021","unstructured":"An T, Chen Y, Tu Y, Lin P. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Treatment of Diabetic Foot Ulcers: Application and Challenges. Stem Cell Rev Rep. 2021;17:369\u201378.","journal-title":"Stem Cell Rev Rep"},{"key":"4991_CR11","first-page":"444","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun F, Sun Y, Wang X, Zhu J, Chen S, Yu Y, et al. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioact Mater. 2024;33:444\u201359.","journal-title":"Bioact Mater"},{"key":"4991_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12951-022-01267-2","volume":"20","author":"N Wang","year":"2022","unstructured":"Wang N, Liu X, Tang Z, Wei X, Dong H, Liu Y, et al. Increased BMSC exosomal miR-140-3p alleviates bone degradation and promotes bone restoration by targeting Plxnb1 in diabetic rats. J Nanobiotechnol. 2022;20:97.","journal-title":"J Nanobiotechnol"},{"key":"4991_CR13","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/molecules25081987","volume":"25","author":"A Artasensi","year":"2020","unstructured":"Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs. Molecules. 2020;25:1987.","journal-title":"Molecules"},{"key":"4991_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s00125-023-05873-z","volume":"66","author":"NG Forouhi","year":"2023","unstructured":"Forouhi NG. Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes. Diabetologia. 2023;66:786\u201399.","journal-title":"Diabetologia"},{"key":"4991_CR15","first-page":"CD003054","volume":"12","author":"B Hemmingsen","year":"2017","unstructured":"Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqu\u00e9 I, Figuls M, Metzendorf M-I, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017;12:CD003054.","journal-title":"Cochrane Database Syst Rev"},{"key":"4991_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"4991_CR17","doi-asserted-by":"publisher","first-page":"e00191","DOI":"10.1042\/BSR20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35:e00191.","journal-title":"Biosci Rep"},{"key":"4991_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/sctm.20-0303","volume":"10","author":"W Li","year":"2021","unstructured":"Li W, Jiao X, Song J, Sui B, Guo Z, Zhao Y, et al. Therapeutic potential of stem cells from human exfoliated deciduous teeth infusion into patients with type 2 diabetes depends on basal lipid levels and islet function. Stem Cells Transl Med. 2021;10:956\u201367.","journal-title":"Stem Cells Transl Med"},{"key":"4991_CR19","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/pharmaceutics14102208","volume":"14","author":"F Sun","year":"2022","unstructured":"Sun F, Sun Y, Wu F, Xu W, Qian H. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. Pharmaceutics. 2022;14:2208.","journal-title":"Pharmaceutics"},{"key":"4991_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, et al. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev. 2020;159:332\u201343.","journal-title":"Adv Drug Deliv Rev"},{"key":"4991_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4991_CR22","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.vesic.2024.100034","volume":"3","author":"Z Ding","year":"2024","unstructured":"Ding Z, Greenberg ZF, Serafim MF, Ali S, Jamieson JC, Traktuev DO, et al. Understanding molecular characteristics of extracellular vesicles derived from different types of mesenchymal stem cells for therapeutic translation. Extracell Vesicle. 2024;3:100034.","journal-title":"Extracell Vesicle"},{"key":"4991_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023;14:66.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR24","first-page":"100394","volume":"4","author":"H Ruan","year":"2023","unstructured":"Ruan H, Li Y, Zheng D, Deng L, Chen G, Zhang X, et al. Engineered extracellular vesicles for ischemic stroke treatment. Innov (Camb). 2023;4:100394.","journal-title":"Innov (Camb)"},{"key":"4991_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.20517\/evcna.2023.22","volume":"4","author":"C Jiang","year":"2023","unstructured":"Jiang C, Liu H, Liao Y, Jiang Y. New insights of engineered extracellular vesicles as promising therapeutic systems. Extracell Vesicles Circ Nucl Acids. 2023;4:191\u20134.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"4991_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transpl. 2016;25:829\u201348.","journal-title":"Cell Transpl"},{"key":"4991_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/sctm.21-0021","volume":"10","author":"L-T Wang","year":"2021","unstructured":"Wang L-T, Liu K-J, Sytwu H-K, Yen M-L, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med. 2021;10:1288\u2013303.","journal-title":"Stem Cells Transl Med"},{"key":"4991_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/pharmaceutics14030649","volume":"14","author":"SK Yap","year":"2022","unstructured":"Yap SK, Tan KL, Abd Rahaman NY, Saulol Hamid NF, Ooi DJ, Tor YS, et al. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats. Pharmaceutics. 2022;14:649.","journal-title":"Pharmaceutics"},{"key":"4991_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/2211-5463.13615","volume":"13","author":"H Shi","year":"2023","unstructured":"Shi H, Hao X, Sun Y, Zhang H, Zhao Y, Wang B, et al. Bone marrow mesenchymal stem cell-derived exosomes reduce insulin resistance and obesity in mice via the PI3K\/AKT signaling pathway. FEBS Open Bio. 2023;13:1015\u201326.","journal-title":"FEBS Open Bio"},{"key":"4991_CR30","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1021\/acsnano.7b07643","volume":"12","author":"Y Sun","year":"2018","unstructured":"Sun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, et al. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving \u03b2-Cell Destruction. ACS Nano. 2018;12:7613\u201328.","journal-title":"ACS Nano"},{"key":"4991_CR31","doi-asserted-by":"publisher","first-page":"9534574","DOI":"10.1155\/2021\/9534574","volume":"2021","author":"R Sharma","year":"2021","unstructured":"Sharma R, Kumari M, Mishra S, Chaudhary DK, Kumar A, Avni B, et al. Exosomes Secreted by Umbilical Cord Blood-Derived Mesenchymal Stem Cell Attenuate Diabetes in Mice. J Diabetes Res. 2021;2021:9534574.","journal-title":"J Diabetes Res"},{"key":"4991_CR32","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3390\/cells11162568","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Bai X, Shen K, Luo L, Zhao M, Xu C, et al. Exosomes Derived from Adipose Mesenchymal Stem Cells Promote Diabetic Chronic Wound Healing through SIRT3\/SOD2. Cells. 2022;11:2568.","journal-title":"Cells"},{"key":"4991_CR33","doi-asserted-by":"publisher","first-page":"e15489","DOI":"10.1016\/j.heliyon.2023.e15489","volume":"9","author":"K Malekpour","year":"2023","unstructured":"Malekpour K, Hazrati A, Soudi S, Roshangar L, Pourfathollah AA, Ahmadi M. Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells. Heliyon. 2023;9:e15489.","journal-title":"Heliyon"},{"key":"4991_CR34","doi-asserted-by":"publisher","first-page":"109126","DOI":"10.1016\/j.diabres.2021.109126","volume":"183","author":"Z-F Han","year":"2022","unstructured":"Han Z-F, Cao J-H, Liu Z-Y, Yang Z, Qi R-X, Xu H-L. Exosomal lncRNA KLF3-AS1 derived from bone marrow mesenchymal stem cells stimulates angiogenesis to promote diabetic cutaneous wound healing. Diabetes Res Clin Pract. 2022;183:109126.","journal-title":"Diabetes Res Clin Pract"},{"key":"4991_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13287-021-02378-7","volume":"12","author":"A Hassanzadeh","year":"2021","unstructured":"Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, et al. Mesenchymal stem\/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021;12:297.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR36","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.scr.2020.101978","volume":"48","author":"K Adlerz","year":"2020","unstructured":"Adlerz K, Patel D, Rowley J, Ng K, Ahsan T. Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles. Stem Cell Res. 2020;48:101978.","journal-title":"Stem Cell Res"},{"key":"4991_CR37","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267\u201374.","journal-title":"Exp Hematol"},{"key":"4991_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641\u201350.","journal-title":"J Orthop Res"},{"key":"4991_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.276.5309.71","volume":"276","author":"DJ Prockop","year":"1997","unstructured":"Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71\u20134.","journal-title":"Science"},{"key":"4991_CR40","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood"},{"key":"4991_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12015-024-10681-y","volume":"20","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang L, Ai J, Li K. Mitochondria in Mesenchymal Stem Cells: Key to Fate Determination and Therapeutic Potential. Stem Cell Rev Rep. 2024;20:617\u201336.","journal-title":"Stem Cell Rev Rep"},{"key":"4991_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13098-025-01619-6","volume":"17","author":"M Kashbour","year":"2025","unstructured":"Kashbour M, Abdelmalik A, Yassin MNA, Abed M, Aldieb E, Abdullah DM, et al. Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2025;17:189.","journal-title":"Diabetol Metab Syndr"},{"key":"4991_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.20517\/evcna.2023.12","volume":"4","author":"D Gupta","year":"2023","unstructured":"Gupta D, Wiklander OPB, Wood MJA, El-Andaloussi S. Biodistribution of therapeutic extracellular vesicles. Extracell Vesicles Circ Nucl Acids. 2023;4:170\u201390.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"4991_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/tra.12558","volume":"19","author":"AE Sedgwick","year":"2018","unstructured":"Sedgwick AE, D\u2019Souza-Schorey C. The biology of extracellular microvesicles. Traffic. 2018;19:319\u201327.","journal-title":"Traffic"},{"key":"4991_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-012-9839-0","volume":"44","author":"C Tetta","year":"2013","unstructured":"Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine. 2013;44:11\u20139.","journal-title":"Endocrine"},{"key":"4991_CR46","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ki.2010.278","volume":"78","author":"G Camussi","year":"2010","unstructured":"Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes\/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78:838\u201348.","journal-title":"Kidney Int"},{"key":"4991_CR47","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/stem.1161","volume":"30","author":"V Fonsato","year":"2012","unstructured":"Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells. 2012;30:1985\u201398.","journal-title":"Stem Cells"},{"key":"4991_CR48","first-page":"20230139","volume":"4","author":"VP Chavda","year":"2024","unstructured":"Chavda VP, Luo G, Bezbaruah R, Kalita T, Sarma A, Deka G, et al. Unveiling the promise: Exosomes as game-changers in anti-infective therapy. Explor (Beijing). 2024;4:20230139.","journal-title":"Explor (Beijing)"},{"key":"4991_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8:1605.","journal-title":"Cells"},{"key":"4991_CR50","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/jcm10132991","volume":"10","author":"R Sanabria-de la Torre","year":"2021","unstructured":"Sanabria-de la Torre R, Qui\u00f1ones-Vico MI, Fern\u00e1ndez-Gonz\u00e1lez A, S\u00e1nchez-D\u00edaz M, Montero-V\u00edlchez T, Sierra-S\u00e1nchez \u00c1, et al. Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review. J Clin Med. 2021;10:2991.","journal-title":"J Clin Med"},{"key":"4991_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/5584_2018_251","volume":"1119","author":"P Goodarzi","year":"2018","unstructured":"Goodarzi P, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Mohamadi-Jahani F, Ranjbaran N, et al. Mesenchymal Stem Cells-Derived Exosomes for Wound Regeneration. Adv Exp Med Biol. 2018;1119:119\u201331.","journal-title":"Adv Exp Med Biol"},{"key":"4991_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2018.10.005","volume":"90","author":"G P\u00e4th","year":"2019","unstructured":"P\u00e4th G, Perakakis N, Mantzoros CS, Seufert J. Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells. Metabolism. 2019;90:1\u201315.","journal-title":"Metabolism"},{"key":"4991_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.22203\/eCM.v041a17","volume":"41","author":"A Ivica","year":"2021","unstructured":"Ivica A, Zehnder M, Weber FE. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in regenerative endodontics. Eur Cell Mater. 2021;41:233\u201344.","journal-title":"Eur Cell Mater"},{"key":"4991_CR54","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/med.21918","volume":"42","author":"MD Hade","year":"2022","unstructured":"Hade MD, Suire CN, Mossell J, Suo Z. Extracellular vesicles: Emerging frontiers in wound healing. Med Res Rev. 2022;42:2102\u201325.","journal-title":"Med Res Rev"},{"key":"4991_CR55","doi-asserted-by":"publisher","first-page":"8825771","DOI":"10.1155\/2020\/8825771","volume":"2020","author":"AG Zhao","year":"2020","unstructured":"Zhao AG, Shah K, Cromer B, Sumer H. Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential. Stem Cells Int. 2020;2020:8825771.","journal-title":"Stem Cells Int"},{"key":"4991_CR56","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41417-022-00427-8","volume":"29","author":"B Sohrabi","year":"2022","unstructured":"Sohrabi B, Dayeri B, Zahedi E, Khoshbakht S, Nezamabadi Pour N, Ranjbar H, et al. Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy. Cancer Gene Ther. 2022;29:1105\u201316.","journal-title":"Cancer Gene Ther"},{"key":"4991_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9:63.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR58","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/ijms21030727","volume":"21","author":"HS Joo","year":"2020","unstructured":"Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM. Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent. Int J Mol Sci. 2020;21:727.","journal-title":"Int J Mol Sci"},{"key":"4991_CR59","doi-asserted-by":"publisher","first-page":"e2203131","DOI":"10.1002\/adhm.202203131","volume":"12","author":"T Yang","year":"2023","unstructured":"Yang T, Dong Y, Wan J, Liu X, Liu Y, Huang J, et al. Sustained Release of BMSC-EVs from 3D Printing Gel\/HA\/nHAP Scaffolds for Promoting Bone Regeneration in Diabetic Rats. Adv Healthc Mater. 2023;12:e2203131.","journal-title":"Adv Healthc Mater"},{"key":"4991_CR60","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s12015-021-10176-0","volume":"18","author":"Q Wei","year":"2022","unstructured":"Wei Q, Wang Y, Ma K, Li Q, Li B, Hu W, et al. Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Diabetic Wound Healing Through MiR-17-5p-mediated Enhancement of Angiogenesis. Stem Cell Rev Rep. 2022;18:1025\u201340.","journal-title":"Stem Cell Rev Rep"},{"key":"4991_CR61","doi-asserted-by":"publisher","first-page":"3281896","DOI":"10.1155\/2022\/3281896","volume":"2022","author":"S Yin","year":"2022","unstructured":"Yin S, Liu W, Ji C, Zhu Y, Shan Y, Zhou Z, et al. hucMSC-sEVs-Derived 14-3-3\u03b6 Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease. Oxid Med Cell Longev. 2022;2022:3281896.","journal-title":"Oxid Med Cell Longev"},{"key":"4991_CR62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13098-023-01191-x","volume":"15","author":"W Fan","year":"2023","unstructured":"Fan W, Zhou M, Zheng S, Liu Y, Pan S, Guo P, et al. Human umbilical cord mesenchymal stem cell-derived exosomes promote microcirculation in aged diabetic mice by TGF-\u03b21 signaling pathway. Diabetol Metab Syndr. 2023;15:234.","journal-title":"Diabetol Metab Syndr"},{"key":"4991_CR63","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058\u201370.","journal-title":"Circ Res"},{"key":"4991_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-022-02983-0","volume":"13","author":"F Sun","year":"2022","unstructured":"Sun F, Sun Y, Zhu J, Wang X, Ji C, Zhang J, et al. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4. Stem Cell Res Ther. 2022;13:293.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR65","doi-asserted-by":"publisher","first-page":"829868","DOI":"10.3389\/fbioe.2022.829868","volume":"10","author":"C Yan","year":"2022","unstructured":"Yan C, Xv Y, Lin Z, Endo Y, Xue H, Hu Y, et al. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Wound Healing via Ameliorating Oxidative Stress and Promoting Angiogenesis. Front Bioeng Biotechnol. 2022;10:829868.","journal-title":"Front Bioeng Biotechnol"},{"key":"4991_CR66","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.18240\/ijo.2021.11.06","volume":"14","author":"X Gao","year":"2021","unstructured":"Gao X, He G-H, Zhang X-T, Chen S. Protective effect of human umbilical cord mesenchymal stem cell-derived exosomes on rat retinal neurons in hyperglycemia through the brain-derived neurotrophic factor\/TrkB pathway. Int J Ophthalmol. 2021;14:1683\u20139.","journal-title":"Int J Ophthalmol"},{"key":"4991_CR67","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.3390\/ijms21249759","volume":"21","author":"A Arthur","year":"2020","unstructured":"Arthur A, Gronthos S. Clinical Application of Bone Marrow Mesenchymal Stem\/Stromal Cells to Repair Skeletal Tissue. Int J Mol Sci. 2020;21:9759.","journal-title":"Int J Mol Sci"},{"key":"4991_CR68","doi-asserted-by":"crossref","unstructured":"Du Y, Yan S, Sun Y, Han X, Shi H, Fan W, et al. Extracellular vesicles secreted by bone marrow stem cells mediate angiogenesis for the treatment of diabetic ulcers: a systematic review and meta-analysis of preclinical studies. Heliyon. 2024;10(4):e25762.","DOI":"10.1016\/j.heliyon.2024.e25762"},{"issue":"Suppl 2","key":"4991_CR69","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S135\u2013148.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4991_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31\u201355.","journal-title":"Immunity"},{"key":"4991_CR71","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63:431\u201343.","journal-title":"Diabetologia"},{"key":"4991_CR72","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.omtn.2019.11.034","volume":"19","author":"B Li","year":"2020","unstructured":"Li B, Luan S, Chen J, Zhou Y, Wang T, Li Z, et al. The MSC-Derived Exosomal lncRNA H19 Promotes Wound Healing in Diabetic Foot Ulcers by Upregulating PTEN via MicroRNA-152-3p. Mol Ther Nucleic Acids. 2020;19:814\u201326.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4991_CR73","first-page":"CD007543","volume":"2012","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;2012:CD007543.","journal-title":"Cochrane Database Syst Rev"},{"key":"4991_CR74","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/ijms22083851","volume":"22","author":"M Pomatto","year":"2021","unstructured":"Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, et al. Differential Therapeutic Effect of Extracellular Vesicles Derived by Bone Marrow and Adipose Mesenchymal Stem Cells on Wound Healing of Diabetic Ulcers and Correlation to Their Cargoes. Int J Mol Sci. 2021;22:3851.","journal-title":"Int J Mol Sci"},{"key":"4991_CR75","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.1074\/jbc.RA120.012522","volume":"295","author":"Y Duan","year":"2020","unstructured":"Duan Y, Luo Q, Wang Y, Ma Y, Chen F, Zhu X, et al. Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy. J Biol Chem. 2020;295:12868\u201384.","journal-title":"J Biol Chem"},{"key":"4991_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10863-021-09919-y","volume":"54","author":"T Zhao","year":"2022","unstructured":"Zhao T, Jin Q, Kong L, Zhang D, Teng Y, Lin L, et al. microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF\/PDK4 axis. J Bioenerg Biomembr. 2022;54:17\u201330.","journal-title":"J Bioenerg Biomembr"},{"key":"4991_CR77","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12951-024-02603-4","volume":"22","author":"S Yang","year":"2024","unstructured":"Yang S, Sun Y, Yan C. Recent advances in the use of extracellular vesicles from adipose-derived stem cells for regenerative medical therapeutics. J Nanobiotechnol. 2024;22:316.","journal-title":"J Nanobiotechnol"},{"key":"4991_CR78","doi-asserted-by":"publisher","first-page":"16983","DOI":"10.1038\/s41598-021-96121-0","volume":"11","author":"N Kotikalapudi","year":"2021","unstructured":"Kotikalapudi N, Sampath SJP, Sukesh Narayan S, Nemani RB, Mungamuri H. The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems. Sci Rep. 2021;11:16983.","journal-title":"Sci Rep"},{"key":"4991_CR79","doi-asserted-by":"publisher","first-page":"tkad010","DOI":"10.1093\/burnst\/tkad010","volume":"11","author":"J Su","year":"2023","unstructured":"Su J, Wei Q, Ma K, Wang Y, Hu W, Meng H, et al. P-MSC-derived extracellular vesicles facilitate diabetic wound healing via miR-145-5p\/ CDKN1A-mediated functional improvements of high glucose-induced senescent fibroblasts. Burns Trauma. 2023;11:tkad010.","journal-title":"Burns Trauma"},{"key":"4991_CR80","doi-asserted-by":"publisher","first-page":"e0165466","DOI":"10.1371\/journal.pone.0165466","volume":"11","author":"D Kadekar","year":"2016","unstructured":"Kadekar D, Rangole S, Kale V, Limaye L. Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells. PLoS ONE. 2016;11:e0165466.","journal-title":"PLoS ONE"},{"key":"4991_CR81","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-021-03883-6","volume":"12","author":"Y Fu","year":"2021","unstructured":"Fu Y, Sui B, Xiang L, Yan X, Wu D, Shi S, et al. Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy. Cell Death Dis. 2021;12:596.","journal-title":"Cell Death Dis"},{"key":"4991_CR82","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2024.02.001","volume":"167","author":"B Sui","year":"2024","unstructured":"Sui B, Wang R, Chen C, Kou X, Wu D, Fu Y, et al. Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration. Gastroenterology. 2024;167:343\u201356.","journal-title":"Gastroenterology"},{"key":"4991_CR83","doi-asserted-by":"publisher","first-page":"e12109","DOI":"10.1002\/jev2.12109","volume":"10","author":"C Zheng","year":"2021","unstructured":"Zheng C, Sui B, Zhang X, Hu J, Chen J, Liu J, et al. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles. 2021;10:e12109.","journal-title":"J Extracell Vesicles"},{"key":"4991_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-023-03490-6","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jing L, Lei X, Ma Z, Li B, Shi Y, et al. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition. Stem Cell Res Ther. 2023;14:257.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR85","doi-asserted-by":"publisher","first-page":"113456","DOI":"10.1016\/j.expneurol.2020.113456","volume":"334","author":"P Venkat","year":"2020","unstructured":"Venkat P, Zacharek A, Landschoot-Ward J, Wang F, Culmone L, Chen Z, et al. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats. Exp Neurol. 2020;334:113456.","journal-title":"Exp Neurol"},{"key":"4991_CR86","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/pharmaceutics14061206","volume":"14","author":"H-H Hsu","year":"2022","unstructured":"Hsu H-H, Wang AYL, Loh CYY, Pai AA, Kao H-K. Therapeutic Potential of Exosomes Derived from Diabetic Adipose Stem Cells in Cutaneous Wound Healing of db\/db Mice. Pharmaceutics. 2022;14:1206.","journal-title":"Pharmaceutics"},{"key":"4991_CR87","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jcmm.13492","volume":"22","author":"C Hu","year":"2018","unstructured":"Hu C, Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med. 2018;22:1428\u201342.","journal-title":"J Cell Mol Med"},{"key":"4991_CR88","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"N Noronha","year":"2019","unstructured":"Noronha N, de Mizukami C, Cali\u00e1ri-Oliveira A, Cominal C, Rocha JG, Covas JLM. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10:131.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR89","doi-asserted-by":"crossref","unstructured":"Wang J, Wu H, Peng Y, Zhao Y, Qin Y, Zhang Y, et al. Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K\/Akt pathways. J Nanobiotechnol. 2021;19(1):202.","DOI":"10.1186\/s12951-021-00942-0"},{"key":"4991_CR90","doi-asserted-by":"publisher","first-page":"tkad058","DOI":"10.1093\/burnst\/tkad058","volume":"12","author":"Y Shi","year":"2024","unstructured":"Shi Y, Wang S, Liu D, Wang Z, Zhu Y, Li J, et al. Exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells facilitates diabetic wound healing by restoring keratinocyte autophagy. Burns Trauma. 2024;12:tkad058.","journal-title":"Burns Trauma"},{"key":"4991_CR91","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13287-020-01756-x","volume":"11","author":"W Liu","year":"2020","unstructured":"Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN\/AKT pathway. Stem Cell Res Ther. 2020;11:259.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR92","first-page":"2450","volume":"13","author":"T Su","year":"2019","unstructured":"Su T, Xiao Y, Xiao Y, Guo Q, Li C, Huang Y, et al. Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MiR-29b-3p Regulates Aging-Associated Insulin Resistance. ACS Nano. 2019;13:2450\u201362.","journal-title":"ACS Nano"},{"key":"4991_CR93","doi-asserted-by":"publisher","first-page":"e2300019","DOI":"10.1002\/adhm.202300019","volume":"12","author":"L Liu","year":"2023","unstructured":"Liu L, Zheng C-X, Zhao N, Zhu T, Hu C-B, Zhang N, et al. Mesenchymal Stem Cell Aggregation-Released Extracellular Vesicles Induce CD31+ EMCN+ Vessels in Skin Regeneration and Improve Diabetic Wound Healing. Adv Healthc Mater. 2023;12:e2300019.","journal-title":"Adv Healthc Mater"},{"key":"4991_CR94","doi-asserted-by":"publisher","first-page":"152327","DOI":"10.1016\/j.bbrc.2025.152327","volume":"777","author":"J Tong","year":"2025","unstructured":"Tong J, Cai X, Wu M, Sui B, Ma C, Zhang H, et al. SHED aggregation-released extracellular vesicles rejuvenate Gli1\u2009+\u2009cells and improve diabetic wound healing. Biochem Biophys Res Commun. 2025;777:152327.","journal-title":"Biochem Biophys Res Commun"},{"key":"4991_CR95","doi-asserted-by":"publisher","first-page":"e2002070","DOI":"10.1002\/adhm.202002070","volume":"11","author":"LJ Born","year":"2022","unstructured":"Born LJ, Chang K-H, Shoureshi P, Lay F, Bengali S, Hsu ATW, et al. HOTAIR-Loaded Mesenchymal Stem\/Stromal Cell Extracellular Vesicles Enhance Angiogenesis and Wound Healing. Adv Healthc Mater. 2022;11:e2002070.","journal-title":"Adv Healthc Mater"},{"key":"4991_CR96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s13287-021-02475-7","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Jiang Y, Huang Q, Wu Z, Pu H, Xu Z, et al. Exosomes derived from adipose-derived stem cells overexpressing glyoxalase-1 protect endothelial cells and enhance angiogenesis in type 2 diabetic mice with limb ischemia. Stem Cell Res Ther. 2021;12:403.","journal-title":"Stem Cell Res Ther"},{"key":"4991_CR97","doi-asserted-by":"publisher","first-page":"113694","DOI":"10.1016\/j.expneurol.2021.113694","volume":"341","author":"B Fan","year":"2021","unstructured":"Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol. 2021;341:113694.","journal-title":"Exp Neurol"},{"key":"4991_CR98","doi-asserted-by":"publisher","first-page":"17844","DOI":"10.1038\/s41598-024-68104-4","volume":"14","author":"MM Gabr","year":"2024","unstructured":"Gabr MM, El-Halawani SM, Refaie AF, Khater SM, Ismail AM, Karras MS, et al. Modulation of na\u00efve mesenchymal stromal cells by extracellular vesicles derived from insulin-producing cells: an in vitro study. Sci Rep. 2024;14:17844.","journal-title":"Sci Rep"},{"key":"4991_CR99","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fphys.2017.00904","volume":"8","author":"Q Shi","year":"2017","unstructured":"Shi Q, Qian Z, Liu D, Sun J, Wang X, Liu H, et al. GMSC-Derived Exosomes Combined with a Chitosan\/Silk Hydrogel Sponge Accelerates Wound Healing in a Diabetic Rat Skin Defect Model. Front Physiol. 2017;8:904.","journal-title":"Front Physiol"},{"key":"4991_CR100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10856-023-06746-y","volume":"34","author":"S Yang","year":"2023","unstructured":"Yang S, Chen S, Zhang C, Han J, Lin C, Zhao X, et al. Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers. J Mater Sci Mater Med. 2023;34:43.","journal-title":"J Mater Sci Mater Med"},{"key":"4991_CR101","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1039\/D2TB02371G","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Song P, Wu L, Su Z, Gui X, Gao C, et al. In situ photo-crosslinked adhesive hydrogel loaded with mesenchymal stem cell-derived extracellular vesicles promotes diabetic wound healing. J Mater Chem B. 2023;11:837\u201351.","journal-title":"J Mater Chem B"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04991-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:02:17Z","timestamp":1778191337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04991-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4991"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04991-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}